These findings suggest that inhibition of RhoA/C or YAP by Rho inhibitors, such as rhosin, suppresses tumor metastasis through the inhibition of RHAMM and CXCR4 expression in breast cancer and melanoma. This evidence concerns the gene CXCR4 and breast cancer.